the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Clinical trial NCT03728543 · UNKNOWN

Trial details

NCT number: NCT03728543
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Anesthesia Pediatric Cancer Pediatric Tumor Pediatric Hepatoblastoma Beta-Thalassemia Hepatic Metastases

Start date: 2018-11-15
Primary completion: 2019-11-15
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.